Amy Sylvester

My interests lie in translational neuroscience and precision psychiatry, particularly how neuropsychological and neuroimaging techniques are combined to predict and tailor treatment response in psychiatric disorders. 

As a research assistant in the Clinical Psychopharmacology research group, I am involved in a number of projects concerning the neurochemistry of psychiatric pathologies, including Chronic Fatigue Syndrome, long-COVID, and treatment-resistant depression. 

My research uses Magnetic Resonance Spectroscopy (MRS), cognitive testing, and neuropsychological assessment in healthy populations and patient groups. We are also developing functional MRS paradigms that will allow us to understand how neurochemistry changes as the brain performs a task, perceives a stimulus, or experiences the effects of a drug. 

Prior to joining the Department of Psychiatry here in Oxford, I completed an MSc in Psychological Research at the University of Edinburgh and a BSc in Neuroscience at the University of St Andrews.